Tegafur

Tegafur

SCHEMBL8537231

O=c1[nH]c(=O)n(C2CCCO2)cc1F.O=c1[nH]c(=O)n(C2CCCO2)cc1F

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

TYMS

The experimentally established mechanism targets of Tegafur. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 1.00
MAPT P10636 2/20 1.00
ESR1 P03372 1/20 1.00
SMN1; SMN2 Q16637 3/20 0.69
ALDH1A1 P00352 2/20 0.69
KMT2A Q03164 2/20 0.69
POLB P06746 1/20 0.69
HPGD P15428 1/20 0.45
TSHR P16473 1/20 0.45
PMP22 Q01453 1/20 0.45
HBB P68871 1/20 0.45
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tegafur SCHEMBL4552 1.00 LMNA (1.00) LMNAMAPTESR1SMN1; SMN2ALDH1A1
Tegafur SCHEMBL7698456 1.00 LMNA (1.00) LMNAMAPTESR1SMN1; SMN2ALDH1A1
Tegafur SCHEMBL4553 1.00 LMNA (1.00) LMNAMAPTESR1SMN1; SMN2ALDH1A1
Tegafur SCHEMBL4155129 0.98 LMNA (0.97) LMNAMAPTESR1SMN1; SMN2ALDH1A1
Tegafur SCHEMBL22320166 0.98 LMNA (0.97) LMNAMAPTESR1SMN1; SMN2ALDH1A1
Tegafur SCHEMBL28304686 0.97 LMNA (0.94) LMNAMAPTESR1SMN1; SMN2ALDH1A1
Tegafur SCHEMBL28156468 0.97 LMNA (0.94) LMNAMAPTESR1SMN1; SMN2ALDH1A1
Tegafur SCHEMBL28851751 0.96 LMNA (0.92) LMNAMAPTESR1SMN1; SMN2ALDH1A1
SCHEMBL10940658 0.95 LMNA (0.91) LMNAMAPTESR1SMN1; SMN2ALDH1A1
Tegafur SCHEMBL1276356 0.90 LMNA (0.81) LMNAMAPTESR1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016089208-A2 SULFONAMIDE, SULFAMATE AND SULFAMIDE DERIVATIVES OF ANTI-CANCER AGENTS STICHTING MAASTRICHT RADIATION ONCOLOGY "MAASTRO-CLINIC" (NL) 2016-06-09 WO claimed
WO-2016089208-A2 SULFONAMIDE, SULFAMATE AND SULFAMIDE DERIVATIVES OF ANTI-CANCER AGENTS STICHTING MAASTRICHT RADIATION ONCOLOGY "MAASTRO-CLINIC" (NL) 2016-06-09 WO disclosed
US-5741900-A REACTING PROTECTED FLUOROURIDINE WITH SUCCINIC ANHYDRIDE, ATTACHING TO LONG-CHAIN ALKYLAMINE CONTROLLED PORE GLASS IN ANHYDROUS PYRIDINE IN PRESENCE OF DIMETHYLAMINOPYRIDINE AND DIMETHYLAMINOPROPYL/ETHYLCARBODIIMIDE THE BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) 1998-04-21 US disclosed